| Catalog No. | HV217026 |
| Host species | Humanized |
| Species reactivity | Human |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG1-kappa |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target | SLAMF7, CRACC, Protein 19A, SLAM family member 7, CD2-like receptor-activating cytotoxic cells, Membrane protein FOAP-12, CD319, Novel Ly9, CD2 subset 1, CS1 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact the lab for this information. |
| Expression system | Mammalian Cells |
| Accession | Q9NQ25 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | ABBV-383, PR-1471272, ABBV-838, 1826819-57-1 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Anti-Human CRACC/SLAMF7 Reference Antibody (Azintuxizumab, RUO)
Overview
Images
 Bioactivity |
SEC-HPLC detection for Research Grade Azintuxizumab. |
 SDS-PAGE |
SDS-PAGE for Research Grade Azintuxizumab |
 Western blot |
Western blot analysis was performed using anti-CD319/SLAMF7 monoclonal antibody at 1μg/ml on various samples. Lane 1: recombinant human CD319/SLAMF7 (Catalog No: HV217012), 50ng Lane 2: recombinant human CD319/SLAMF7 (Catalog No: HV217012), 30ng |